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We have isolated cDNAs for four human genes (DPDE1 through DPDE4) closely related to the dnc learning
and memory locus ofDrosophila melanogaster. The deduced amino acid sequences of the Drosophila and human
proteins have considerable homology, extending beyond the putative catalytic region to include two novel,
highly conserved, upstream conserved regions (UCR1 and UCR2). The upstream conserved regions are located
in the amino-terminal regions of the proteins and appear to be unique to these genes. Polymerase chain reaction
analysis suggested that these genes encoded the only homologs of dnc in the human genome. Three of the four
genes were expressed in Saccharomyces cerevisiae and shown to encode cyclic AMP-specific phosphodiesterases.
The products of the expressed genes displayed the pattern of sensitivity to inhibitors expected for members of
the type IV, cyclic AMP-specific class of phosphodiesterases. Each of the four genes demonstrated a distinctive
pattern of expression in RNA from human cell lines.
Regulation of cyclic AMP (cAMP) is important in central
nervous system (CNS) function in both invertebrates and
mammals. Studies of two different invertebrates in particular
have demonstrated a role for cAMP in learning and memory.
InAplysia snails, long-term facilitation of neurons in the gill
retraction reflex occurs with learning. These neuronal
changes are associated with alterations in activity of several
components of the cAMP signalling pathway, particularly
adenylyl cyclase and a cAMP-dependent protein kinase (32).
In Drosophila melanogaster, numerous mutations in genes
affecting learning have been isolated, including dunce (dnc),
which encodes a cAMP-specific phosphodiesterase (PDE),
and rutabaga (rut), which encodes a calcium-calmodulin-
stimulated adenylyl cyclase (10, 16, 28). Electrophysiologic
studies of neurons from dnc- and rut- flies have shown
alterations in synaptic plasticity, suggesting that the func-
tional changes occurring in learning in wild-type flies are
similar to those seen in Aplysia snails (40). These observa-
tions suggest that modulation of the cAMP pathway can
influence learning and memory in organisms widely sepa-
rated in evolution.
Evidence for a functional role of dunce-like PDEs in the
mammalian CNS initially came from the development of
specific inhibitors. Inhibitors of cAMP-specific PDEs, in-
cluding the drug rolipram, have clinical activity as antide-
pressants (11). The initial biochemical analysis of mamma-
lian CNS PDEs, and of these inhibitors, was limited to
testing in partially purified preparations, which can contain
multiple PDE isoforms (1). More recently, cDNAs for ho-
mologs of dnc have been cloned from rats (5, 7, 9, 36-38) and
shown to be rolipram sensitive (14, 37, 38). One of these
homologs, DPD, was cloned by us in the course of develop-
ing genetic screens for mammalian genes that interact with
the RAS-cAMP pathway in the yeast Saccharomyces cere-
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visiae. Although the rat dnc homologs are encoded by at
least four different genes, only two cDNAs encoding a dnc
homolog have been isolated from humans (17, 24). In this
report, we demonstrate that four human dnc-related loci
exist and that the diversity of dunce-related gene products is
further augmented by isoforms generated by alternative
splicing. We also provide evidence that our human homologs
are targets for antidepressant drugs.
MATERUILS AND METHODS
All procedures not detailed below were performed as
described by Sambrook et al. (31). Procedures involving S.
cerevisiae were performed as described by Rose et al. (29).
Degenerate primer PCR. Polymerase chain reactions
(PCRs) (30) were initially performed with DNA isolated from
cDNA libraries as a template. To reduce background in the
PCRs from the XZAP vector arms, the plasmid pBluescript,
containing the cDNA insert, was excised in vivo, with a
mass scale-up of the procedure previously described (34). A
total of 200 ng of this DNA was used in PCRs, with Taq
polymerase (30). PCR conditions consisted of 40 cycles of
94°C for 1 min 30 s, 55°C for 3 min, and 72°C for 5 min. The
oligonucleotide primers used in these reactions (pairs
HDUN3 and HDUN5, HDUN4 and HDUN11, and HDUN4
and HDUN6, respectively [Table 1]) represented the degen-
erate coding sequence (or its complement) of regions con-
served between the rat DPD gene and dnc (Fig. 1 and 2).
PCR was also performed on first-strand cDNA, which was
synthesized from polyadenylated RNA isolated from human
temporal cortex (obtained from patients undergoing surgery
for epilepsy, but grossly normal in appearance). RNA was
isolated by the guanidine thiocyanate-cesium chloride
method (20), and first-strand cDNA was prepared with
oligo(dT) priming and avian myeloblastosis virus reverse
transcriptase (31). Approximately 200 ng of cDNA was used
in PCRs as described above. PCR was also performed on
genomic DNA, with either 10 ng of DNA from genomic
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TABLE 1. PCR primers used in this study'
Name Sequence, 5' to 3' Translation Location'
HDUN3 GAGGTACCACYTTYTTNGTYTCNACCAT MVETKKVc 459
HDUN4 CTAGCAGTGCGGTACCGCCCANGTYTCCCANARNGG PLWETWAC 552
HDUN5 GAATTCATHCAYGTNGAYCAYCC IHDVDHIP 372
HDUN6 CGATGCTACGGAATTCGAYATGWSNAARCAYATG DMSKHM 445
HDUN11 CGATGCTACGGAATTCAARATGGTNATHGAYATNGT KMVID(I/M)V 435
HDUN20 CTAGCAGTGCGTTACCACNATRTCDATNACCATYTT KIIVID(I/M)VC 435
HDUN24 CGATGCTACGGAATTCTTYAARYTNYTNCARGRNGA FKLLQ(E/A)E 411
a The abbreviations for positions containing degeneracies are as follows: H = A or C or T; N = A or C or G or T; R = A or G; S = C or G; W = A or T; Y
= C or T.
b Location on the dnc sequence (Fig. 2A).
c Primes off the noncoding strand.
clones (see below) or 200 ng of human placental DNA, in
reactions otherwise identical to those described above.
To analyze the PCR products, the reaction was purified by
agarose gel electrophoresis and the DNA was cleaved at the
restriction sites in the PCR primers and cloned into pUC119
(31). The inserts of approximately 80 recombinant clones
from each PCR were then individually sequenced. For this
purpose, single-strand template was prepared by PCRs as
described above, but with primers recognizing sequences on
the pUC119 plasmid, added to the PCR in a 1:0.005 molar
ratio. The primers had the following sequences (5' to 3'):
AACAGCTATGACCATGATTA and AGGGTTITCCCAG
TCACGAC. This template was then used in sequencing
reactions with Sequenase, in a modification of the proce-
dures outlined by the manufacturer (United States Biochem-
ical, Cleveland, Ohio). The changes from the standard
protocol were as follows: (i) as a sequencing primer, an
oligomer (M13-20 primer; New England Biolabs) was la-
belled with 32P by using kinase; (ii) the 31S-dATP and the
initial elongation step were both omitted; and (iii) manganese
was used in all reactions.
Hybridization screening of cDNA and genomic libraries.
Initial screening used the complete insert from the rat DPD
cDNA clone (5) at low stringency (hybridization, 6x SSC
[lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate]-0.5%
sodium dodecyl sulfate [SDSJ, 50°C; final wash, 0.1x SSC-
0.1% SDS, 500C), to screen a human temporal cortical
cDNA library. Incomplete cDNA clones from three different
loci (DPDEs 2, 3, and 4) were isolated, and these were
subsequently used to screen other libraries in an attempt to
obtain longer ones. These libraries contained cDNA derived
from human fetal brain (the source of pPDEs 39, 43, and 46),
human frontal cortex (pPDE32), or human temporal cortex
(pPDE21), cloned into the EcoRI site of XZAP (Stratagene,
La Jolla, Calif.). They were screened at high stringency (as
above, but with a final wash of 0.1x SSC-0.1% SDS at
68°C). Genomic clones were isolated from a human placental
DNA library cloned into XFIX II (Stratagene). pTM72,
pPDE46, pPDE43 (or clones corresponding to various re-
gions thereof) and the complete insert of pPDE21 were used
as probes. Screening was performed at high stringency (final
wash, 0.1x SSC-0.1% SDS, 68 to 70°C).
Northern (RNA) blotting and RNase protection analysis.
For Northern blotting, polyadenylated RNA from human
temporal cortex (see above) was electrophoresed through
formaldehyde-ararose, transferred to nitrocellulose (31), andhybridized to [ P]dCTP-labelled probes generated by ran-
dom priming. The probe for pTM72 corresponded to nucle-
otides (nt) 2422 to 3181. For pPDE46, pPDE43, and pPDE21,
the probes corresponded to the sequence from codons 693 of
pPDE46, 611 of pPDE43, and 222 of pPDE21, respectively
(Fig. 2A), to the 3' noncoding regions of these clones (nt
2733 for pPDE46, 2788 for pPDE43, and 1155 for pPDE21).
Washing was at high stringency (final wash, 0.1x SSC-0.5%
SDS, 68°C), and exposure was for 7 days at -700C, with
intensifying screens.
For RNase protection analysis, total RNA was isolated
from human tumor cell lines (20). All the cell lines used are
available from the American Type Culture Collection (Rock-
ville, Md.). Total RNA was also similarly isolated from
testes removed from patients undergoing therapy for carci-
noma of the prostate. Single-stranded antisense RNA probes
were generated from appropriate regions of the four cDNAs,
cloned under the control of the SP6 promoter (in pGEM3Zf
or pGEM4Zf [Promega, Madison, Wis.]). The probes were
designed to hybridize to the regions of the mRNAs encoding
the divergent carboxyl termini of the dunce proteins. For
pPDE46, the probe corresponded to the sequence from
codons 693 to 768 (Fig. 2A). For the other cDNAs, the
probes were located in noncoding DNA 3' to the termination
codon, i.e., for pTM72, nt 2828 to 3181; for pPDE43, nt 2628
to 2788; and for pPDE21, nt 786 to 1155. RNase protection
assays were performed as described previously (31). RNase
digestion was done with 20 ,ug ofRNA per assay and RNases
A and T1 (Worthington) for 1 h at 30°C. Autoradiograms of
the gels were exposed for 5 days at -70°C.
Construction of clones for biochemical and pharmacological
assays. Fragments of pTM72, pPDE46, pPDE43, and the dnc
type II cDNA were cloned into the NotI site ofpADANS (6).
All the resulting constructs produced a transcript generated
off the S. cerevisiae alcohol dehydrogenase promoter and
contained 13 amino acids at their amino termini derived from
the alcohol dehydrogenase gene product, in frame with the
open reading frame (ORF) of the human cDNA. These
constructs were designed to provide an initiation sequence
known to function in S. cerevisiae. The inserts were gener-
ated by PCR, with Pfii polymerase, as described previously(19). PCRs were performed with 20 cycles of 94°C for 1 min
30 s, 65°C for 2 min, and 720C for 5 min. NotI sites were
incorporated into the PCR primers to aid in subsequent
cloning.
PDE activity assay. Cells used in biochemical and pharma-
cologic studies were isolated at mid-log phase of growth at
30°C on selective medium (SC-leucine). Pellets containing
approximately 1010 cells (1 g [wet weight]) were resuspended
in 20 mM Tris-HCl (pH 8.0)-5 mM EDTA-5 mM EGTA
[ethylene glycol-bis(,-aminoethyl ether)-N,JT,N',N'-tetra-
acetic acid]-1 mM o-phenanthroline-0.1 mM 4-(2-amino-
ethyl)-benzenesulfonylfluoride-1 mM benzamidine-10 p,g of
leupeptin per ml-10 p,g of pepstatin per ml-10 ,ug of aprotinin
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per ml-10 ,ug of both calpain inhibitors I and II per ml. Cells
were lysed by rapid mixing with glass beads and centrifuged
at 10,000 x g for 10 min to remove cell debris. Aliquots of
the supematant were assayed for PDE activity immediately
or stored at -80°C for later analysis. Protein was measured
by the method of Bradford (3) with a kit (Pierce, Rockford,
Ill.).
Cyclic nucleotide PDE activity was assayed as previously
described, with modifications (22, 25). Assays were per-
formed in vinyl microtiter plates at 30°C. Incubation mix-
tures contained 40 mM Tris-Cl (pH 8.0), 1 mM EGTA, 5 mM
magnesium chloride, 0.1 mg of bovine serum albumin per ml,
diluted enzyme, [3H]cAMP (1.3 to 7.5 ,uCi/ml; NEN Inc.,
Boston, Mass.), [14C]AMP (0.11 pLCi/ml; NEN Inc.), and
various amounts of unlabelled cyclic nucleotides in a total
volume of 100 ,ul. Assays were performed for 15 min. Three
minutes prior to termination of the reaction, 5 ,ul of Crotalus
atrox snake venom 5' nucleotidase (Sigma, St. Louis, Mo.;
15 mg/ml) was added. The assays were terminated by adding
50 RI of 20 mM Tris-Cl (pH 7.5)-100 mM EDTA-0.15%
cetylpyridinium chloride. The nucleoside products were
separated from the unreacted cyclic nucleotides by anion-
exchange chromatography on Sephadex A-25 (Pharmacia,
Piscataway, N.J.) columns (8 by 30 mm). After sample
application, the columns were washed with 0.25 ml of 25 mM
Tris-Cl, pH 7.5, and then eluted with three applications (0.5
ml) of the same buffer. The eluate was mixed with EcoLume
ICN Biochemicals, Irvine, Calif.) and analyzed for 3H and
4C content by dual-channel liquid scintillation spectros-
copy. The recovery of 3H nucleotide reaction products were
corrected for the recovery of [14C] AMP.
For estimation of kinetic parameters, the PDE assays
utilized a constant radioisotopic specific activity of 0.03
,uCi/nmol of [3H]cAMP. Initial rates of hydrolysis were
determined from five duplicate fourfold dilutions of the
initial extract stock, with cAMP concentrations ranging from
0.1 to 300 p,M. Only those enzyme dilutions that yielded less
than 30% hydrolysis of the total substrate in 15 min were
included in the final rate determination. The kinetic data
were fit to a Michaelis-Menten model with TableCurve
(Jandel Scientific, San Rafael, Calif.) to obtain estimates of
the apparent Km. Vm., (enzymatic specific activity), and
associated errors. The model used the equation
y = (ax)I(b + x), wherey is velocity,x is [cAMP], a is Vm.,
and b is Km.
Inhibitor analysis was performed with 1 ,M cAMP as the
substrate. Milrinone and IBMX were from Sigma; rolipram
was from BIOMOL Research Laboratories (Plymouth Meet-
ing, Pa.); 8-methoxy-IBMX was a kind gift from Jack Wells,
Vanderbilt University; and zaprinast was a kind gift from
Paul Feldman, Glaxo Inc. Research Institute (Research
Triangle Park, N.C.). Denbufylline and cilostamide (OPC
3689) were synthesized by published procedures (13, 18).
Inhibitory compound stocks were initially made up in 100%
dimethyl sulfoxide (Aldrich), and final dimethyl sulfoxide
concentrations in the PDE assay never exceeded 1% (volV
vol). Data were normalized to protein concentration and
represent estimates of initial rates, determined by incuba-
tions at multiple enzyme dilutions.
Dose-response inhibitory curves were fitted with a four-
parameter logistic dose-response model described by the
equationy = a + bI[1 + (xIc)d], wherey is percent total PDE
activity, a is the minimum activity level, b is the maximal
activity level, c is the inhibitor concentration at 50% maxi-
mal activity (IC50), x is the inhibitor concentration, and d is
a parameter that determines the slope of the curve at the
IC50. The four-parameter model was used for fitting the
inhibitor data because the inhibitory curves frequently
spanned a broader range of inhibitor concentrations than
would be fit accurately by a simpler model. The ability to
adjust the slope inherent in the four-parameter logistic curve
permitted a better fit to these data. However, for certain data
sets, a two-parameter model was used to provide an estimate
of the IC50; it is described by the equationy = bI[1 + (xlc)],
where y is percent total PDE activity, b is the maximal
activity level, c is the IC50, andx is the inhibitor concentra-
tion. This model assumes a baseline of zero activity and does
not permit variation in the slope at the IC50. It was used for
two categories of data sets: (i) when activity could not be
reduced to baseline, even at high inhibitor concentrations
(i.e., IC50 greater than 500 pLM), or (ii) when data sets were
too variable to estimate the baseline.
Nucleotide sequence accession numbers. The sequences in
this paper have been communicated to the GenBank/EMBL
data bases under the following accession numbers: L20965,
L20966, L20967, L20968, L20969, L20970, and L20971. The
human locus names in this paper have been communicated
to the Human Genome Nomenclature Committee.
RESULTS
Cloning of human dunce-like PDEs. The initial objective of
this study was to clone cDNAs for all homologs of dnc in the
human genome. For this purpose, three independent meth-
ods were utilized. The first approach used PCR to amplify
human cDNA with homology to sequences present in both
dnc and rat DPD. This approach was used to analyze cDNA
from several regions of human brain, and four different
sequences, each highly homologous to dnc, were obtained.
The second approach used low-stringency hybridization,
with the DPD cDNA as a probe, to probe cDNA libraries
from human brain. This approach yielded cDNA clones
which collectively contained the same four sequences ob-
tained by PCR. These cDNA clones are described in more
detail below. The third approach was to isolate cDNAs that
could suppress the heat shock-sensitive phenotype of strains
of S. cerevisiae with mutations in the RAS-cAMP pathway.
Activating mutations of this pathway produce at least a
portion of their phenotype by raising intracellular cAMP
levels, and introduction of an exogenous PDE into these
cells can lower cAMP levels sufficiently to restore heat
shock resistance. Two different screens, both previously
reported (6, 25), were performed on a cDNA library from a
human glioblastoma cell line. One of these screens isolated
suppressors of the S. cerevisiae RAS2Val-l9 mutation, while
the other yielded supressors of an S. cerevisiae strain
(1ODAB) with disruptions of both endogenous PDE genes.
Both these screens generated cDNAs encoded by several
different human genes. Only some of these clones were
homologous to dnc, and only these are described here.
These three approaches demonstrated that four different
human loci, which we call DPDE1, DPDE2, DPDE3, and
DPDE4, encode cDNAs strongly homologous to that of dnc.
The longest and most complete of the cDNAs from each of
these loci are presented in Fig. 1. The clones pPDE21,
pPDE32, pPDE39, pPDE43, and pPDE46 were all obtained
from the low-stringency screen described above. The pTM3
and pTM72 clones were isolated from the S. cerevisiae
genetic screens.
Putative alternative splicing and other variants of the
DPDE2, -3, and -4 transcripts. Comparison of the sequences
of different cDNAs from the DPDE2, -3, and -4 genes
MOL. CELL. BIOL.
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FIG. 1. cDNAs from the four human dunce loci, aligned with
those from the Drosophila dnc locus. Regions of variant sequence in
the clones from each locus are shown by branched lines. Areas of
common sequence are shown by merged lines. Vertical dashed lines
indicate homologous divergence points that occur in clones from
different loci. The positions of putative initiation and termination
codons are marked by small boxes and asterisks, respectively.
Regions of strong sequence conservation are shown in the areas
defined by hatched boxes. The UCR1 consensus is not found in
pPDE32. Roman numerals indicate the various alternatively spliced
isoforms from the dnc locus (28). The small inverted triangle above
the dnc cDNA indicates the location of the alternatively spliced
exon 4 seen in some of these isoforms (types I, II, and IVA). Exon
3 of dnc is found between these two points of alternative splicing.
The small inverted triangles above the DPDE2 cDNAs indicate the
positions of the insertions in pTM3.
revealed that each locus produced clones with regions of
variant sequence (Fig. 1). The most common variations were
seen in the DPDE2 and DPDE3 loci and consisted of
substitutions of blocks of sequences 5' to the phenylalanine
codon which marks the start of homology between the
human and Drosophila cDNA clones (Fig. 1 and 2). This
location is homologous to the beginning ofdnc exon 3, where
considerable alternative splicing occurs (28).
Two cDNA clones (pPDE32 and pTM72) from the DPDE4
locus also contained alternative coding sequences at their 5'
end (Fig. 1 and 2B). The point of divergence is not known to
be an alternative splice site in dnc, but does correspond to
one of the insertions in pTM3 (see below). The deduced
amino acid sequences of the alternative amino-terminal
regions showed no obvious homology to each other, but the
sequences of both were strongly conserved (76 and 74%
exact amino acid homology, respectively) for alternative
transcripts from the corresponding locus in rats (2).
Finally, one clone, pTM3, contained two insertions of
blocks of sequence, which disrupt its ORF. These blocks are
not seen in pPDE46 or in any other cDNA clone we have
isolated from this locus and have no sequence homology to
any human or Drosophila gene. Splice consensus sequences
are apparent at three of the four ends of these blocks. We
believe that these blocks are improperly spliced introns and
that pTM3 encodes a protein that is unlikely to be normally
found in human cells but can function genetically in S.
cerevisiae (possibly by initiating translation 3' to the inser-
tions). The insertions occur at points of alternative splicing
in the dnc or human loci (Fig. 1), suggesting that at least
some of the genomic structure of the dunce genes is con-
served in evolution.
Further analysis of mRNA and genomic DNA is needed to
confirm that our variant clones are alternatively spliced
isoforms, as opposed to unprocessed RNA transcripts, or
processing intermediates. However, it is unlikely that they
arose as artifacts of ligation, as each of the variants (except
the insertions in pTM3) was seen in at least two different
cDNA clones. Additional mRNA variants from these loci
may also exist.
The alignment of Drosophda and human dunces. Sequence
analysis of the seven human dunce-like cDNA clones in Fig.
1 showed that four of them (pPDE46, pPDE43, pPDE32, and
pTM72) contain complete ORFs, with stop codons in all
three reading frames upstream of the putative initiation
ATG. The ORF of pPDE39 is open at its 5' end, and a
possible initiation ATG is shown in Fig. 2A, although the
ORF may continue amino terminal to this point. pPDE39
also ends at amino acid 419 of pPDE43, before the termina-
tion codon of DPDE3 transcripts is reached. The ORF of
pPDE21 is open at its 5' end but continues to its putative
termination codon. pTM3 contains a single ORF that is
disrupted by the insertions (see above), as well as by several
single-nucleotide deviations from the corresponding se-
quence of pPDE46, which may represent sequence ambigu-
ities or polymorphisms. The termination codons of dnc and
the cDNAs for the DPDE1, DPDE3, and DPDE4 loci are all
within 20 codons of each other (Fig. 1 and 2A), whereas that
of pPDE46 is located about 100 codons 3' to this region. The
sequence of pPDE46 3' to this region is identical to that of
pTM3 and other clones we have isolated for this locus.
The alignment of the deduced amino acid sequences of
these clones showed impressive homology to dnc (Fig. 2A
and 3). Alternative mRNA splice variants of dnc that did not
contain exon 4 required the fewest gaps for alignment (Fig.
1) (28). The homology begins at the phenylalanine corre-
sponding to the beginning of dnc exon 3 and then becomes
very striking in two regions of homology, neither of which
has been previously recognized, that we call upstream
conserved regions (UCR1 and UCR2). UCR1 and UCR2 are
separated from each other, and from the catalytic region
closer to the carboxyl terminus, by regions of lower homol-
ogy in which there is also heterogeneity in length. The
beginning of UCR2 also corresponds to the point of putative
alternative splicing in the DPDE4 locus (i.e., pTM72 con-
tains UCR1 but pPDE32 does not). In contrast, the N-ter-
minal alternate regions of the genes were strongly divergent.
Neither Drosophila nor human sequences showed any ho-
mology in these regions, with the exception of a single block
of conserved amino acids (12 of 15 identical) in the pPDE46
and pPDE39 clones (Fig. 2B).
Comparison of the dunce PDE sequences to those of other
families of cyclic nucleotide PDEs shows both conserved
and novel features. The dunce catalytic region has weak, but
significant, homology (approximately 30% amino acid iden-
tity) to the catalytic regions of other PDE classes (1, 9, 25,
36). The UCR1 and UCR2 regions, however, have no
apparent homology to the sequence of any non-dunce PDE,
or with those of any other genes in the EMBL, GenBank,
and Swiss Protein data bases. The strong evolutionary
conservation of the UCR1 and UCR2 regions among the
dunce PDEs suggests that they are important in dunce PDE
function (see Discussion).
Livi et al. have isolated a dunce-like PDE cDNA from a
human blood monocyte line which corresponds to our
pPDE46 but is truncated at its amino terminus (17). How-
ever, this truncated cDNA includes the complete catalytic
region and encodes a biochemically active, rolipram-inhib-
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B
TM3 1 glgripelqlvafpvavaaedeaflpeplapr
33 aprrprsppsspvffaspsptfrrrlrllrscqdlgrqawagagfeaenq--
PDE46 1 mepptvpsersls
14 lslpgpregqatlkpppqhlwrqprtpiriqqrgysdsaeraererqphr
64 pieradamdTsdRPGLrttRMSWPSSFhGtgtgsggagggssrrfeaena--
1111: :11111111 1
PDE39 1 mdrtsyaveTghRPGLkksRMSWPSSFqG ..... ....... lrrfdvdnq--
PDE43 1 mmhvnnfpfrrhswicfdvdna--
TM72 1 mkksrsvmtvmaddnvkdyfecslsksyssssntlgidlwrgrrccsgnl
50 qlpplsqrqserartpegdgisrpttlplttlpsiaittvsqecfdvena--
PDE32 1 mkehggtfsstgisggsgdsamdslqplqpnympvclfaees Qk--
FIG. 2. Deduced amino acid sequences of the cDNAs of the four
human dunce genes. The nucleotide sequences are available from
GenBank. (A) Alignment of the homologous portions of pTM72,
pPDE46, pPDE43, and the type IVB splicing product of dnc (exons
3 to 13, excluding exon 4 [28]). The available sequence from pPDE21
is also shown. Alignments were performed with the MACAW
program (33). The two upstream conserved regions, UCR1 and
UCR2, are delineated with heavy horizontal lines. The small trian-
gles above the alignments indicate the positions of the insertions in
pTM3. (B) The deduced amino acid sequences of the amino-terminal
regions of the cDNA clones. Sequence that overlaps with the
alignment in panel A is underlined. Capital letters and vertical lines
(or colons) show the area of sequence conservation between
pPDE39 and pPDE46. Dots and dashes indicate gaps which facilitate
these alignments. Note that the sequence of pPDE39 may continue
aminoterminal to the methionine shown here (see Results).
ited PDE. The DNA sequence of their clone also contains a
number of single-nucleotide changes which alter their ORF
5' from the proline at position 103 of pPDE46 (Fig. 2A). We
believe that the deduced amino acid sequence upstream from
this point of pPDE46 is correct, because it is conserved in
the homologous regions of the Drosophila, DPDE3, and
DPDE4 genes. The data of Livi et al. may reflect sequencing
or cloning errors in this region, although the presence of
polymorphisms cannot be rigorously excluded. More re-
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cently, McLaughlin et al. have isolated a clone whose
deduced amino acid sequence is identical to that of our
pPDE32 (24).
Enumeration of the human genes. To search for additional
dnc homologs in the human genome, the PCR approach used
initially in this study for cDNA was extended to genomic
DNA. Genomic DNA was studied because not necessarily
all dunce-like PDE loci could be expressed in the cDNA
libraries that were studied previously. We prepared PCR
primers corresponding to the fully degenerate codons of nine
different regions of amino acids that were conserved be-
tween the Drosophila, human, and rat dunce genes. Pairs of
these primers (a total of 19 pairs) and either human genomic
DNA, human dunce cDNA clones, or human dunce genomic
clones were used in PCRs as described above. When
genomic DNA was used as a template, the majority of these
primer pairs each produced several PCR products. These
were of different sizes, all larger than those produced by that
pair with cDNA. When genomic clones were used as tem-
plates, they each produced single bands, identical in size to
one of those seen with genomic DNA as a template. We
therefore inferred that each of the bands with genomic DNA
was produced from a different gene, by priming off se-
quences separated by an intron. The products were of
different sizes because the lengths of these introns presum-
ably varied among the dunce genes. However, two of the
PCR primer pairs each produced a single band from genomic
DNA, which was identical in size to those from the genomic
clones and to that from cDNA. We concluded that these
single bands were produced by priming off sequences lo-
cated on a single exon. The PCR products produced from
genomic DNA by one of these primer pairs (HDUN24 and
HDUN20 [Fig. 2B; Table 1]) were cloned, and sequences
from 79 individual clones were analyzed. Four different
sequences were obtained: 9 from DPDE1, 29 from DPDE2,
25 from DPDE3, and 16 from DPDE4. No other PCR
products homologous to dnc were found, and therefore, we
UCR UCR2 CATALYTIC
-1 . -
0 200 400
l
600 800
Amino Acid Position
FIG. 3. Quantitative assessment of homology among the full-length cDNA clones for dnc, pPDE46, pPDE43, and pTM72, as measured by
the PLOTSIMILARITY program (12). Bars indicate UCR1, UCR2, and the approximate location of the catalytic region, respectively. The
horizontal dashed line indicates the margin of significance.
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FIG. 4. Northern blotting of human brain polyadenylated RNA
with probes from the human dunce cDNAs. Approximately 5 p,g of
RNA was applied per lane, each of which was individually hybrid-
ized to probes from the 3' regions of one of the human dunce PDE
cDNAs. Lanes 1 through 4 are with probes from pPDE46 (DPDE2
locus), pTM72 (DPDE4), pPDE43 (DPDE3), and pPDE21 (DPDE1),
respectively.
conclude that there are likely to be only four dnc homologs
in humans. We cannot totally exclude the existence of a
homolog that, by chance, failed to anneal to these primers.
Southern blo-ing and gene mapping have demonstrated that
each human dnc homolog occurs as a single copy (26). We
therefore attribute the differing abundances of the PCR
products we obtained in this experiment to varying efficiency
of PCR priming.
A total of four homologs of dnc have also been isolated
from rats (5, 7, 9, 36, 37). We show elsewhere (2) that the rat
genes have a 1:1 correspondence with their human counter-
parts. This pairwise relationship is apparent only upon
comparison of coding sequences that lie outside the putative
catalytic regions, not all of which are included among
currently published rat dunce cDNA sequences. The human
DPDE1 through DPDE4 loci each correspond, respectively,
to the genes encoding ratPDE1 through ratPDE4 described
by Swinnen et al. (36). Using the nomenclature of Beavo and
Reifsnyder (1), our DPDE1 locus encodes the PDE isozyme
IVc, DPDE2 encodes isozyme IVA, DPDE3 encodes
isozyme IVD, and DPDE4 encodes isozyme IVB (see also
Discussion).
Tissue distribution of the human dunce homologs. The
expression and structure of the human dunce-like genes in
the CNS was studied by Northern blotting. The probes in
this study were specific to each of the four genes and
recognized sequences 3' to the consensus sequence QFELT
LEE, which greatly differ among the four genes (Fig. 2B)
(see Materials and Methods). With a probe for pTM72,
bands of 4.6 and 4.0 kb in size were seen in polyadenylated
RNA from surgically removed normal human temporal cor-
tex. A band of 4.5 kb was seen with a pPDE46 probe, and the
pPDE43 and pPDE21 probes produced no clearly detectable
signal (Fig. 4). The 4.5-kb band detected by pPDE46 in brain
tissue is similar to that observed by others in human tissues
outside the CNS, with a similar probe (17). The two bands
detected by pTM72 are also similar to those observed in a
variety of human tissues by others using a similar probe (24).
Since we obtained clones corresponding to pPDE43 and
pPDE21 from a cDNA library derived from the same region
of the human brain (temporal cortex) as the mRNA used in
our Northern blots, we believe that these two genes also
express transcripts in this region, although at very low
levels.
The expression of the human homologs was also studied
by RNase protection (Fig. 5). For this purpose, we prepared
antisense RNA probes specific to each of the four genes,
which, as in the Northern analysis, recognized sequences 3'
to the sequence QFELTLEE (see Materials and Methods).
Analysis of total RNA from various cell lines with these
probes demonstrated significant differences in expression
among the four genes. Among the cell lines tested, tran-
scripts from the DPDE1 locus appeared to be restricted to
those of neuronal origin (the retinoblastoma line Y79 and the
neuroblastoma line SK-N-SH). In contrast, transcripts from
the DPDE2 locus were expressed in almost all the cell lines,
although at different levels. Transcripts from the DPDE3 and
DPDE4 loci were each present in distinctive patterns. Al-
though these data are obtained from cell lines derived from
tumors, they demonstrate that each of the DPDE loci can be
expressed in a distinctive cell-specific pattern. In contrast to
the data obtained by others with rats (36, 37), we saw little or
no expression of the human dunce genes in the testis (lane 8,
Fig. 5A to D). We believe that this reflects differences among
these species, although the possibility of technical factors
cannot be totally excluded.
Biochemical and pharmacologic properties of the dunce
genes. To examine the biochemical and pharmacologic prop-
erties of the dunce PDEs, cDNA clones for dnc and three of
the human genes (DPDEs 2, 3, and 4) were expressed in S.
cerevisiae lODAB, in which both endogenous PDE genes
have been genetically disrupted (5). To ensure that any
biochemical differences observed between the dunce genes
reflected variations in their homologous coding regions,
rather than potential differences in 5' alternative splicing (see
above), we prepared slightly truncated constructs of cDNAs
from dnc (type II splice variant) and the three human loci, all
of which started at the phenylalanine codon homologous to
that at the beginning of dnc exon 3 (Fig. 1). Full-length
constructs of the dnc type II and pTM72 cDNA clones were
also analyzed. PDE assays were performed by a modifica-
tion of previously described methods (22, 25). Because the
pPDE21 clone encoded only a portion of the predicted
protein, it was not tested in these assays.
The slightly truncated dnc, pTM72, pPDE46, and pPDE43
constructs all showed cAMP PDE activity (Fig. 6; Table 2).
There was no detectable difference in biochemical activity
between the truncated form of dnc and its full-length con-
struct (Table 2). We have also observed no difference
between the full-length pTM72 clone and its truncated con-
struct (21). The Km for cAMP for the three human clones
ranged from 7 x 10-6 to 1.8 x 10-5 M, which was greater
than that previously reported for mammalian cAMP-specific
PDEs (0.5 x 10-6 to 4 x 10-6 M [7]). The Km for cAMP for
the full-length and truncated forms ofdnc was approximately
3 x 0-5 M and about 3- to 15-fold higher than that
previously reported for preparations of cAMP-specific PDE
activity extracted from tissues of D. melanogaster (8, 14,
28).
We studied the effect of a number of PDE inhibitors on the
activity of the human and D. melanogaster clones (Fig. 7;
Table 3). The ability of these compounds to inhibit the
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FIG. 5. RNase protection assays. Antisense RNA probes from the divergent 3' regions of the cDNAs were used to probe RNA from
various human tissues and cell lines. (A to D) Probes from pTM72 (DPDE4 locus), pPDE21 (DPDE1), pPDE46 (DPDE2), and pPDE43
(DPDE3), respectively. Lanes: 1, transfer RNA; 2, glioblastoma line U118; 3, retinoblastoma line Y79; 4, neuroblastoma line SK-N-SH; 5,
lung small cell carcinoma line Calu 3; 6, testicular embryonal carcinoma line Cates 1B; 7, T-lymphoblast line Molt 3; 8, normal human testis;
9, probe without RNase. Size markers (base pairs) are MspI-digested pBR322. The bands representing the protected RNA fragments are
marked by the arrowheads. The predicted size of the pPDE43 probe was 160 nt, which corresponds to the smaller of the two bands seen on
the gel. (E) Summary of the data in panels A through D. The signal produced by each RNA source, as determined visually from the
autoradiograms, is presented relative to that of other samples with the same probe.
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FIG. 6. Effect of cAMP concentration on the velocity ofPDE activity associated with full-length cDNA clones for pTM72 (A) and dnc (B).
Three separate pellets, derived from yeast cells harboring the respective plasmids, were lysed, and extracts were prepared as described in
Materials and Methods. Hydrolytic rates as a function of the amount of enzyme were determined for eight substrate concentrations ranging
from 1 x 10-7 to 3 x 10-4 M. The main graphs in both panels show specific activity as a function of cAMP concentration. The smooth curve
describes the fit of a Michaelis-Menten model through the datum points. The error bars represent the standard error of the slope of the line
fitted to the datum points determining the initial rates. (See Materials and Methods for details of data analysis.) The inset in each panel shows
a Lineweaver-Burk transformation of the velocity data corresponding to substrate concentrations from 1 x 10-6 to 3 x 10-4 M. The lowest
two concentrations of substrate were excluded from the plot to expand the axes.
human dunce-like PDEs displayed a pattern of potency
expected for a cAMP-specific PDE. All were inhibited by
IBMX, a nonspecific cyclic nucleotide PDE inhibitor, with
no detectable difference in the concentration needed to
produce 50% inhibition (IC50). Inhibitors specific to other
classes of PDEs, such as milrinone or cilostamide (inhibitors
of cGMP-inhibited PDEs), 8-methoxy IBMX (an inhibitor of
calcium-calmodulin-dependent PDEs), or zaprinast (an in-
hibitor of cGMP-specific PDEs), produced some inhibition,
but at IC50s 10- to 1,000-fold higher than those for their
specific PDE classes (1, 27). All three human clones were
markedly inhibited by the antidepressant drug rolipram, an
inhibitor of the cAMP-specific PDEs, with IC50s of 0.2 to 0.5
,uM. The human dnc homologs were also inhibited by
denbufylline (Table 3), an additional specific inhibitor of
cAMP-specific PDEs. Dose-response curves for rolipram
(Fig. 7B) and denbufylline inhibition of the human clones
showed a relatively flat dose-response curve, which spread
over 3 log units of inhibitor concentration. This property is
consistent with the complex inhibitory kinetics previously
reported for the human dnc homologs cloned by other
groups (17, 24, 38).
The three human clones shared similar biochemical and
pharmacologic properties. We were unable to detect more
than a sixfold difference in the Km for cAMP, and less than
a threefold difference in the IC50 for denbufylline or roli-
TABLE 2. Summary of kinetic analysis for dunce PDE clonesa
Locus Plasmid Km (SD) in AM Sp act (nmol/min/mg)
DPDE2b pADH46R 18 (5.9) 21-64
DPDE3b pADH43 8 (2.2) 54-138
DPDE4b pADH72 7.2 (2) 29-50
dncb pADDROSF 27 (16) 0.8-5.6
dnc pADDROSC 32 (9.5) 0.6-2.5
a Kinetic parameters were obtained for the hydrolysis of [3HI cAMP (0.1 to
300 FM) from supematants of yeast extracts derived from cells harboring the
indicated plasmids. Values were determined in duplicate from three separate
cell pellets. Each value for the Km represents the average of six determina-
tions, with the standard deviation shown in parentheses. The specific activity
at Vma,, is reported as the range of determinations for the six experiments. All
parameters were estimated with a Michaelis-Menten model as described in
Materials and Methods.b cDNAs truncated at amino-terminal end, as described in Results.
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FIG. 6-Continued.
pram, among these clones (Table 3). For some of the
cAMP-specific inhibitors, the pharmacologic properties of
the human clones differed from those of dnc. The dnc gene
product was not inhibited by rolipram or by Ro 20-1724
(IC50s of >1,000 ,uM). Denbufylline exhibited substantial
inhibitory activity for the Drosophila dnc clones (IC50 = 1 to
3 ,uM), although this activity is still approximately 10-fold
lower than that for the human enzymes. Thus, the human
and Drosophila cAMP-specific PDEs share many character-
istics yet can be distinguished by specific inhibitors.
DISCUSSION
We have isolated cDNAs from four human loci with
extensive homology to the dnc memory and learning gene of
D. melanogaster. PCR analysis strongly suggested that these
loci are the only ones encoding close homologs of dnc in the
human genome. Biochemical and pharmacologic analysis of
proteins encoded by cDNAs from three of the four human
genes showed them to be cAMP-specific PDEs which were
inhibited by the antidepressant drug rolipram. Northern
blotting and RNase protection studies suggested that each of
the genes has a distinctive pattern of cellular expression. The
close homology of the human genes to dnc, their expression
in the brain and in other tissues, and the inhibition of their
encoded proteins by a drug with psychoactive properties
suggests that they have an important functional role.
The human and Drosophila dunce genes share significant
structural features with other cyclic nucleotide PDEs. How-
ever, the degree of homology among the dunce genes is
much higher than that with any other PDE. Mammalian
PDEs are divided into subgroups according to their biochem-
ical and pharmacologic properties: I, Ca2+-calmodulin-de-
pendent PDEs; II, cGMP-stimulated PDEs; III, cGMP-
inhibited PDEs; IV, cAMP-specific PDEs, which include the
dunce PDEs; V, cGMP-specific PDEs; VI, photoreceptor
PDEs; and VII, high-affinity, cAMP-specific PDEs (1, 25).
All the vertebrate and insect PDEs that have been isolated to
date contain a putative catalytic domain, located in the
carboxyl one-third of the protein, with approximately 28 to
34% amino acid identity (1, 7, 9, 17, 25, 36). Evidence that
this region contains the catalytic regions of the dunce PDEs
has been shown by mutagenesis studies (15). The catalytic
domains of members of any one PDE class are more strongly
related than those of any two different classes, with, typi-
cally, 60 to greater than 90% homology. Outside the catalytic
region, there is no region of sequence common to all PDE
classes. However, the members of each class often share
additional sequence motifs. These motifs are located in the
amino termini of the protein and are generally postulated to
have regulatory functions (1). For example, the type I PDEs
are regulated, at least in part, by a presumptive calmodulin-
interaction domain near their amino termini, and the type II
PDEs are regulated by a cGMP-binding domain in the
amino-terminal region of the protein. The interaction of the
type VI PDEs with the G-protein transducin is also felt to
occur in their amino-terminal regions (4, 35).
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FIG. 7. Effect of IBMX (A) or roliprama (B) on enzyme activity of extracts from yeast cells harboring the following plasmids, as described
in Table- 3:- nADDROSCr (open c-ircl-es) p%AnnROSF1 (crosses), pADH472 (asterisks), pATDH46RM (fcls ed crr-,cl) and pATDH43 (triangles).
Dose-response inhibitory curves were calculated as described in Materials and Methods.
6568
 o
n
 April 19, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
HUMAN TYPE IV PDEs 6569
Our data show that dnc and its human homologs also
contain a class-specific amino-terminal sequence motif. This
motif is present in the 5' region of our clones, a region
absent, at least in part, from the rat or human dnc homologs
reported previously (5, 7, 9, 17, 24, 36-38). The D. melano-
gaster dnc sequence, as most recently reported, is strongly
homologous to this region of the human dunce-like genes
(28). We have also shown (2) that the homology of the rat
dunce-like genes extends further at the amino terminus than
previously reported (5, 7, 9, 36-38). These amino-terminal
regions contain two blocks of strong sequence homology,
which we call UCR1 and UCR2, for upstream conserved
regions (Fig. 1 and 2). UCR1 and UCR2 of humans and D.
melanogaster, respectively, show more homology to each
other than to any other sequences in the GenBank or EMBL
data bases. UCR1 and UCR2 appear to be distinct, in that
they lack homology to each other and are separated by a
region of relatively low homology. Additionally, UCR1, but
not UCR2, probably undergoes alternative splicing (e.g., in
the pPDE32 clone [Fig. 1 and 2B]). Although the function of
these regions is not known, sequence motifs that are strongly
conserved in evolution are often functionally important. We
speculate that UCR1 and UCR2, like the amino-terminal
sequence motifs of other PDE classes, may have regulatory
functions. One possibility is that UCR1 and/or UCR2 bind to
other cellular proteins or cofactors. We are currently testing
these hypotheses.
Our biochemical and pharmacologic analysis of human
and Drosophila dunce clones demonstrates both similarities
and differences between the proteins encoded by these
genes. The Drosophila and human proteins have a similar
Km for cAMP but differ from 10- to several hundredfold in
their IC50s for mammalian cAMP-specific PDE inhibitors.
Our data also show that the biochemical and pharmacologic
properties of our three human clones are very similar. The
physical basis for these differences and similarities is not
clear. One possibility is the structure of the catalytic sites of
these proteins. Alternatively, other aspects of the proteins,
such as secondary modifications, resistance to proteolysis,
or other properties, may explain our data. Although we were
unable to obtain a full-length clone from the DPDE1 locus
for testing in these assays, we expect that the biochemical
properties of such a clone would be highly similar to those of
the other human DPDE genes.
Our biochemical and pharmacologic data can be compared
with those previously published by other groups. Two
studies of the proteins encoded by human dunce cDNA
clones expressed in mammalian cells or in S. cerevisiae have
been published. Torphy et al. reported a Km for the enzyme
hPDE IV (which corresponds to a truncated version of the
pPDE46/DPDE2 protein that we have analyzed) that is
sixfold less than the Km we report for pPDE46 (17, 39).
McLaughlin et al. (24) reported a Km for hPDE IVb, which
corresponds to the splice variant of DPDE2 encoded by our
pPDE32 clone, that is threefold less than the one we mea-
sured for this protein (21). Our data can also be compared
with those of mammalian type IV enzymes extracted from
natural sources (see Results and reference 7). The differ-
ences between these data and our results could reflect
numerous factors. The results obtained for enzyme prepara-
tions derived from tissues or cells could reflect the contri-
bution of several different PDE isozymes, as some of the
reported preparations may not have been purified to homo-
geneity. Partial proteolysis (23) or other modifications could
have occurred during the extraction or assay of our proteins.
A potential limitation of our expression system is that yeast
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cells may lack cellular functions needed for appropriate
folding or secondary modification of the PDEs, or cofactors
needed for physiologically complete enzyme function. The
constructs may also be expressed at different levels, which
may explain, for example, the lower specific activities we
have obtained for the Drosophila clones, compared with the
human ones (Table 2). Variations in assay methodology may
account for some of the discrepancies: for example, many of
the studies previously reported did not include substrate
concentrations greater than 100 ,M, and some did not
exceed 30 ,uM. Finally, our recombinant proteins are de-
signed to contain the first 13 amino acids from S. cerevisiae
alcohol dehydrogenase fused to the amino terminus of the
PDE, which may alter its kinetic properties.
Several lines of evidence suggest, but do not prove, that
the mammalian dunce-like PDEs are the major in vivo
targets for rolipram and other type IV PDE inhibitors.
Biochemical and pharmacologic studies to date have failed
to isolate any other enzymes that are inhibited as strongly by
these drugs as are the type IV enzymes (1, 27). Binding
studies have shown that the Kd of rolipram (approximately 1
nM) for cloned human dunce-like PDEs is similar to the
concentration needed for therapeutic action in vivo (24, 39).
Interestingly, this value is approximately 1,000-fold lower
than that needed for enzyme inhibition. The reason for this
discrepancy is unclear, but it may be related to the flattened
inhibition curves that we and others have observed for many
of the type IV-specific inhibitory compounds such as roli-
pram (see above and references 17, 24, and 39). The binding
and inhibitory data both strongly support the use of cloned
human dunce-like genes, expressed in S. cerevisiae, in
assays for specific dunce PDE inhibitors (17, 24, 39).
The functions of the human dunce-like PDEs in the cell, or
in the intact organism, remain open to speculation. It is also
unclear whether these functions might differ among the four
genes or among the different PDE isoforms produced by any
one locus. The dnc locus was first isolated as a mutation
affecting learning and memory in D. melanogaster (10), and
cAMP pathways are important in learning in other organ-
isms, notably Aplysia snails (33). The antidepressant effect
of rolipram and other type IV PDE inhibitors suggests that
the dunce genes also play an important function in the
human CNS. However, dunce PDEs are expressed widely in
tissues outside the CNS, and type IV PDE inhibitors may
have other actions, including anti-inflammatory or immuno-
modulatory properties (1, 27, 39). Genetic approaches may
be a powerful method of analyzing the functions of the
mammalian dnc homologs. We and our collaborators (26)
have determined the genetic mapping of the human and
murine dnc homologs. Mapping the position of these loci
may reveal an association of one of the genes with a
previously described mutation. Study of such a mutation in
turn may provide insight into the functions of the gene.
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